A recent report suggesting that the Department of Justice (DOJ) is examining venture capital firm Andreessen Horowitz for its board memberships in competing AI companies has left many in the investment community baffled.
On a recent episode of the Equity podcast, hosts Kirsten Korosec, Sean O’Kane, and I expressed our confusion over this development. While conflicts of interest in venture capital are certainly serious, Kirsten raised an important question: “Why is this particular issue receiving such focused attention from the DOJ?”
The situation is particularly noteworthy given Andreessen Horowitz’s connections to the Trump administration and their previous silence regarding this investigation, which sharply contrasts with the firm’s vocal activity during Biden’s presidency. As Sean pointed out, “Each minor policy update during the Biden administration, especially concerning crypto, led to a flood of social media activity from them.”
Sean also suggested that the DOJ’s focus on Andreessen could be an effort to set a precedent for other, smaller firms to follow.
Here’s a summary of our discussion, condensed for clarity.
Kirsten Korosec: Anthony brings a unique viewpoint to our discussion, having worked in a VC firm, unlike Sean and myself, who have only reported on the industry.
Anthony Ha: Regular listeners of our show know that I spent a few years at an early-stage VC firm, which, while much smaller than Andreessen Horowitz, still provided insights into the industry dynamics. My perspective was influenced by Andreessen’s holding board positions in firms that have now become rivals.
This revelation shocked me, and I assume many other venture capitalists share my sentiment. I am not a legal expert, but there are established guidelines suggesting that one should not sit on the boards of competing companies. However, this rule is seldom enforced stringently.
Startups continuously change their focus, especially in a fast-evolving sector like AI. It’s not uncommon for a company to pivot drastically in response to market demand. Hence, a year-long DOJ investigation into this matter seems excessive and puzzling.
Kirsten: For instance, Ben Horowitz serves on the board of Databricks, while partner Martin Casado is on the Fivetran board. Given the AI boom, many companies are adapting their strategies, which could lead to such overlaps in board memberships. It’s intriguing—Sean, what are your thoughts on the DOJ’s choice to target this issue?
Sean O’Kane: I’m intrigued by this potential for disruption. Imagine a startup that places AI on your board to avoid conflicts of interest! It’s just odd for various reasons. When I first heard about the investigation, I was curious about its specifics.
Let’s backtrack; Bloomberg reported that the investigation has been ongoing for nearly a year, starting during the Trump administration. The leaders at Andreessen Horowitz have had close ties with Trump, even participating in some advisory roles.
Despite the administration’s claims of pushing antitrust initiatives, little action followed—settling with firms rather than breaking them up. The DOJ’s choice to pursue this case raises questions about its impartiality, especially given the close relationship between Andreessen and the administration.
Previously, I reported on issues involving Andreessen that may have an anti-competitive angle. For example, Ben Horowitz’s connections between backed startups and law enforcement departments raised eyebrows. In light of this, the ongoing investigation appears to be sparked more by circumstance than blatant wrongdoing.
Interestingly, Andreessen has not reacted vocally about this investigation, contrasting their responses to policy changes during the Biden era. This quietness suggests they may not see this situation as a significant overreach.
Anthony: To Sean’s point regarding the DOJ’s credibility, the political climate has led to questions about impartiality. The prolonged investigation is perplexing, especially when it involves a firm viewed as an ally.
The investigation’s duration hints at unresolved issues beyond surface-level concerns with board memberships. If it were merely about those positions, the resolution could have been straightforward.
Kirsten: It’s possible for both a slow DOJ process and underlying serious issues to coexist. Their calm demeanor could indicate they are heeding legal counsel, suggesting something significant might be at play.
My concern is how this affects other venture capital firms. Are they observing closely, or do they dismiss this as a rare occurrence that allows them to continue their board seat practices without concern?
Sean: That’s a valid query. If this investigation signals serious concerns in the DOJ’s antitrust division, targeting Andreessen might serve as a warning to smaller firms. Rather than pursuing numerous smaller players, they could be setting an example through this larger firm.
Interestingly, this administration has shifted focus away from prosecuting public companies, favoring individual accountability instead. So, while Andreessen is in question, it raises the possibility that the DOJ’s priorities are influencing their attention on matters like this.
